lantheus.com - LNTH Company profit before taxes, interest and amortization

Public company logo of Lantheus (LNTH)

Lantheus Holdings, Inc. (LNTH) is implementing environmental standards for radioisotope operations, which is supported by operational financial results currently priced in around 380.96. The company generates revenue through innovative imaging agents for cardiology and oncology. High patent barriers and complex isotope logistics provide the business with exceptional protection against new market entrants.

LNTH - Lantheus Operating profit EBITDA over the range 11/23/2025 - 11/16/2026

Summary analytical data breakdowns for Lantheus Corp (LNTH)

- share price and expert price forecast:
Fundamental company valuation:Lantheus Holdings, Inc.
Original product of Lantheus Medical Imaging

Lantheus Holdings, Inc. (LNTH) maintains high authority in precision diagnostics, ensuring stable demand for its agents, which translates directly into daily operating profit. Analyzing the absolute EBITDA trend, an investor sees a liquidity flow stripped of noise; however, the upward trajectory of the curve necessitates caution to avoid purchasing the asset at a local peak and the subsequent freezing of capital.